Corxel

CORXEL is a clinical-stage biopharmaceutical company developing innovative therapies for patients with diverse cardiometabolic conditions worldwide.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series D‑1
Initial Investment Year
2026
Corxel Portco Hover Image2